中国生化药物杂志2017,Issue(4) :255-257.DOI:10.3969/j.issn.1005-1678.2017.04.084

右美托咪定对瑞芬太尼麻醉患者痛觉过敏缓解的有效性

Effectiveness of dexmedetomidine to alleviate hyperalgesia of remifentanil anesthesia patients

王益兵 金丽萍
中国生化药物杂志2017,Issue(4) :255-257.DOI:10.3969/j.issn.1005-1678.2017.04.084

右美托咪定对瑞芬太尼麻醉患者痛觉过敏缓解的有效性

Effectiveness of dexmedetomidine to alleviate hyperalgesia of remifentanil anesthesia patients

王益兵 1金丽萍1
扫码查看

作者信息

  • 1. 浙江省台州医院 麻醉科,浙江 台州 317000
  • 折叠

摘要

目的 探讨右美托咪定对瑞芬太尼麻醉患者痛觉过敏缓解的有效性.方法 选取2014年12月~2016年4月期间择期行腹腔镜全子宫切除术的84 例患者,随机分为观察组和对照组,每组各42 例,2 组均于术中静脉输注瑞芬太尼、丙泊酚和吸入七氟醚维持麻醉.观察组于手术结束前40 min 予以0.6 μg/kg 的右美托咪定(加入100 mL 0.9%氯化钠溶液中,10 min 内缓慢滴注);对照组患者予以相同容量0.9%氯化钠溶液.分别采用视觉模拟评分法(visual analogue scale,VAS)和舒适评分量表(bruggrmanncomfort scale,BCS)对2 组患者的不同时间节点的术后疼痛程度以及舒适程度进行评估,以及对2 组患者的不良反应发生情况进行客观比较.结果 2 组患者的VAS 评分在术后1 h(T1)、4 h(T2)和24 h(T3)时差异显著,且观察组患者VAS 评分明显更优于对照组,差异有统计学意义( P <0.05);2组的BCS评分在T1、T2时比较,差异有统计学意义( P <0.05),但T3差异无统计学意义;同时,观察组的不良反应发生情况更低于对照组,差异有统计学意义( P <0.05).结论 右美托咪定减轻和防止瑞芬太尼麻醉患者痛觉过敏和不良反应的发生,且有效提高了患者术后的镇痛效果.

Abstract

Objective To investigate the efficacy of dexmedetomidine in reduce of hyperalgesia in patien with remifentanil anesthesia.Methods 84 patients scheduled for laparoscopic hysterectomy from December 2014 to April 2016 were selected and randomly divided into two groups: the observation group and the control group,42 cases in each group,two groups were intravenous infusion of remifentanil,propofol and inhaled sevoflurane to maintain anesthesia.In the observation group,0.6μg/kg of dexmedetomidine was given 40minutes before the end of the operation(adding to 100mL 0.9%sodium chloride solution,infusion within 10minutes),the control group was given the same volume of 0.9%sodium chloride solution.The visual analogue scale(VAS)and the bruggrmann comfort scale(BCS)were used to evaluate the postoperative pain and comfort of the two groups of patients at different time points,and compare the incidence of adverse events between the two groups.Results The VAS scores of the two groups were significantly different at 1h(T1),4h(T2)and 24h(T3),and the VAS score of the observation group was significant better than that of the control group,the difference was statistically significant(P<0.05),the BCS scores of two group were compared at T1 and T2,the difference was statistically significant(P<0.05),but there was no significant difference between the two groups at T3.The incidence of adverse reactions in the observation group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion Dexmedetomidine can relieve and prevent the incidence of hyperalgesia and adverse reactions in patients with remifentanil anesthesia,and improve the analgesic effect of postoperative patients.

关键词

右美托咪定/瑞芬太尼/麻醉/镇痛

Key words

dexmedetomidine/remifentanil/anesthesia/analgesia

引用本文复制引用

出版年

2017
中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
被引量8
参考文献量12
段落导航相关论文